IntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtained)

SAINT LAURENT, Quebec, Aug. 31, 2023 -- IntelGenx Technologies Corp. announces the closing of the first tranche of a non-brokered private placement of units from atai Life Sciences AG for...

Related Keywords

Canada ,Quebec ,Germany ,Toronto ,Ontario ,United States ,Berlin ,Saint Laurent ,Canadian ,Andre Godin ,Stephen Kilmer ,Exchange Commission ,Company The Acquisition ,Securities Of The Company ,Company Manual The Insider Shareholder Approval ,Intelgenx Technologies Corp ,Life Sciences ,Company The ,Toronto Stock Exchange ,Company Manual ,Securities Exchange ,National Instrument ,Party Transactions ,Genx Technologies ,Shareholder Approvals ,Cdn Unit ,Cdn Notes ,Cdn Warrants ,General Cap ,Insider Cap ,Restated Loan ,Loan Agreement ,Second Amendment ,Call Option Units ,Call Option ,Subscription Agreement Amendment ,Conversion Feature ,General Shareholder Approval ,Insider Shareholder Approval ,Loan Amendment ,Multilateral Instrument ,Minority Security Holders ,Special Transactions ,Early Warning System ,Related Take Over Bid ,Insider Reporting Issues ,Initial Notes ,Initial Warrants ,Subsequent Notes ,Subsequent Warrants ,Call Options ,United States Securities Act ,Securities Exchange Act ,Securities Act ,United States Securities ,Markets ,